-
Star stylists reveal secrets of making splash on Cannes red carpet
-
World Cup could make football 'mainstream' in co-host Canada
-
India postpones big cat summit over Ebola outbreak
-
Thousands line streets to celebrate Villa's Europa triumph
-
Trump eases curbs on planet-warming gases used in refrigerants
-
Clinical Gujarat end Chennai IPL hopes with 89-run win
-
What's behind the social unrest in Bolivia?
-
Air France, Airbus convicted of manslaughter in 2009 Rio-Paris crash
-
Trump pressures Supreme Court to rule for him on citizenship
-
UK details rules for single-sex spaces after landmark ruling
-
First Gaza flotilla activists arrive in Turkey after Israel deportation
-
Beloved Citroen 2CV revived as electric car
-
UK net migration halves in 2025 in boost for beleaguered Starmer
-
Rubio warns Cuba after US indicts former leader
-
Court ousts leadership of Turkey's main opposition party
-
US voices hope on Iran deal progress before Pakistan army chief visit
-
Maguire 'shocked' to be omitted from England World Cup squad
-
US expects 'below normal' Atlantic hurricane season
-
Trump eases 'ridiculous' curbs on greenhouse gases used in refrigerants
-
Ineos-owned Nice in disarray before French Cup final against Lens
-
US Democrats release - and disown - 2024 election autopsy
-
First Gaza flotilla activists arrive in Istanbul from Israel: AFP
-
Ghana delays evacuation of 800 citizens from South Africa
-
Air France, Airbus convicted of manslaughter in 2009 Paris-Rio crash
-
From conflict to cleaning, expo showcases China's drone dominance
-
Belgium's Segaert snatches Giro 12th stage, Eulalio stays in pink
-
Fans create AI-generated team songs ahead of World Cup
-
Italy and Spain urge EU sanctions on Israeli minister for activists' treatment
-
Senegal have 'big dreams' for 2026 World Cup
-
'People thought it was witchcraft': DR Congo's Ebola outbreak
-
Arteta on BBQ duty as Arsenal clinched Premier League title
-
Top UN court says right to strike protected in key labour treaty
-
Musk's SpaceX bonus comes with unique condition: colonize Mars
-
Guardiola's Premier League legacy carried forward by Spanish coaches
-
Walmart reports solid results but sees some consumers struggling
-
Oil gains, stocks slip on uncertain Mideast peace prospects
-
Stellantis unveils 60 bn euro push to revive profitability
-
French films tackle war and fascism as crunch election looms
-
Italian divers in Maldives may have got lost in cave: recovery firm
-
Do tennis players really only take 15 percent of Grand Slam revenues?
-
Sinner, Djokovic kept apart in French Open draw
-
In Ankara, DW journalist goes on trial for 'insulting president'
-
Arteta alone in garden when Arsenal clinched Premier League title
-
EU countries urge sanctions on Israeli minister for activists' treatment
-
EU slashes eurozone 2026 growth forecast on Mideast war
-
Chinese authorities demolish villager's madcap 10-storey home
-
Air France, Airbus guilty of manslaughter in 2009 Paris-Rio crash: French court
-
Lustrinelli succeeds Eta as Union Berlin coach
-
Alex Marquez out of Italy, Hungary MotoGP races after crash
-
'French Banksy' and Daft Punk star turn Paris bridge into Alpine cave
Independent Evaluation Confirms Breakthrough Performance of BioLargo's Cellinity Battery Technology for Grid-Scale Energy Storage
WESTMINSTER, CALIFORNIA / ACCESS Newswire / June 18, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that a third-party evaluation has confirmed key advantages for its Cellinity battery technology's use in grid-scale battery energy storage applications.
The evaluation was conducted by U.S. BESS Corporation (www.usbesscorp.com), an expert provider of advanced energy storage solutions for critical infrastructure applications spanning utilities, defense, microgrids, and heavy industry.
U.S. BESS senior technical staff performed an examination of Cellinity's design and assembly protocols, inspection of testing infrastructure, review of data from test results, and an assessment of methodologies used for performance characterization, concluding that the following performance characteristics exclusive of any auxiliary systems are supported by their observations and are reasonably representative of the current Cellinity cell's demonstrated behavior:
Open circuit voltage: > 4.2 V
Operating temperature range: from 120°C to 250°C
Energy density: > 500 Wh/kg (calculated based on active material)
Power density: > 500 mW/cm3 (maximum observed value of 1579 W/kg at 230°C)
Charge capacity: Cell can be charged to 100% of theoretical capacity
Charge/discharge efficiency: ~100%
Energy efficiency: 95% at 230°C; 87% at 120°C
Self-discharge: No measurable self-discharge observed over test durations
Thermal cycling durability: Performance unaffected after repeated cycling
U.S. BESS Corp further concluded that it is reasonable to claim that a) the cell would not experience any thermal runaway, b) materials of construction are commonly available and can be domestically sourced, c) the cell does not contain any rare earth elements, and d) cell components are fully recyclable.
A Market Ready for Disruption
The global demand for grid-scale energy storage is rapidly growing to meet the rising loads driven by artificial intelligence, decarbonization mandates, and accelerated adoption of renewables. In 2024 alone, the U.S. Energy Information Administration (www.eia.gov) reported a 66% increase in U.S. battery energy storage capacity. While lithium-ion batteries currently dominate the market, they present known challenges: fire risks from thermal runaway, efficiency losses over time, and sourcing constraints related to rare and critical minerals.
BioLargo's Cellinity battery technology (www.biolargoenergy.com) overcomes these limitations by leveraging novel materials and architecture to deliver both exceptional thermal performance and operational efficiencywithout relying on rare earth elements.
Validation Supports Commercial Pathway
The U.S. BESS report concludes: "Based on our inspection and the evidence provided, U.S. BESS finds that the Cellinity Cell demonstrates a sufficient performance profile, with strong indications of high thermal stability, efficiency, energy and power density, and material sustainability, to suggest further investment in testing and commercialization. These attributes position this technology as a potential solution for critical gaps in grid-scale energy storage markets."
Randall Moore, Chief Technology Officer at BioLargo Energy Technologies, Inc., commented, "Our work to scale up the cell design, refine manufacturing techniques, and integrate cells into a functional module for commercial scale testing is underway."
CEO, Dennis P. Calvert commented, "We do not know of any long duration energy storage technology that can match Cellinity's technical claims for cost effective performance and safety. This third-party evaluation is an important piece of the puzzle for our business plan to bring Cellinity to the world through manufacturing joint ventures. We have several of these in development with potential partners and look forward to sharing more intel about those soon."
About U.S. BESS Corp
U.S. BESS Corp is a U.S.-based company that provides energy storage solutions for a wide range of applications, including utilities, industrial needs, microgrids and defense. With decades of combined experience in battery engineering, microgrid deployment, system-level integration, and manufacturing, the company's leadership team is uniquely qualified in the battery energy storage system industry. U.S. BESS is creating the most advanced and secure battery management system and building the largest domestic battery supply in the USA.
U.S. BESS Corp Contact Information
Mark Hagedorn
CEO, U.S. BESS Corp.
503-720-9569
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
BioLargo Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
P.Silva--AMWN